Elenbaas, Jared S. http://orcid.org/0000-0002-9612-7764
Pudupakkam, Upasana
Ashworth, Katrina J. http://orcid.org/0000-0001-7862-6503
Kang, Chul Joo
Patel, Ved
Santana, Katherine http://orcid.org/0000-0001-5413-2963
Jung, In-Hyuk
Lee, Paul C.
Burks, Kendall H. http://orcid.org/0000-0003-0740-7834
Amrute, Junedh M. http://orcid.org/0000-0002-6851-0168
Mecham, Robert P. http://orcid.org/0000-0002-4020-9277
Halabi, Carmen M. http://orcid.org/0000-0003-4889-8131
Alisio, Arturo http://orcid.org/0000-0003-2907-7215
Di Paola, Jorge http://orcid.org/0000-0002-1461-2871
Stitziel, Nathan O. http://orcid.org/0000-0002-4963-8211
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F30HL152521, R01HL159171, R01HL131961)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1HG008853)
Article History
Received: 28 July 2022
Accepted: 30 January 2023
First Online: 15 February 2023
Change Date: 17 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-37005-x
Competing interests
: N.O.S. has received investigator-initiated research funds from Regeneron Pharmaceuticals unrelated to the content of this study. J.S.E., I.H.J., A.A., and N.O.S. are co-inventors on a patent application filed by Washington University focused on SVEP1 and PEAR1. The other authors declare no competing interests.